Patient Partners needed for colorectal cancer research project team

[Annette McKinnon]

The Project:
Site specific immunomodulators (SSIs) are a new class of therapy, made from dead bacteria. This therapy is
designed to help the body’s own defense system (‘immune cells’) fight cancer. SSIs may be a potential new
treatment for colorectal cancer and have already been shown to be safe in cancer patients. Our team of
scientists and clinicians are planning a clinical trial to determine if SSIs can increase the number of patients
who survive colorectal cancer metastatic to the liver. The trial will start this Fall and is being led by Dr. Rebecca
Auer (Ottawa) and Dr. Paul Karanicolas (Sunnybrook).

Why do we need your help?
We want patients and family members to help us
shape our research, which aims to improve the
experience of trial participants.
We are currently looking for patients, caregivers,
or family members to join our team. As a part of
our team, you will:
• Participate in group meetings (online
and/or in person) with the research team
from May 2022 to March 2024
• Help brainstorm and draft resources and
documents for future trial participants
• Provide input on research to evaluate the
usefulness of the developed resources
Who can apply?

We are looking for individuals with any of the
following:
• A patient, family member, or a caregiver,
with lived experience of colorectal cancer,
liver metastases, and/or liver surgery
• Interested in helping shape research to
assess a new therapy for colorectal cancer
No previous experience with SSIs or research is
necessary. An orientation session will provide
more information about the research project, and
we encourage you to ask any questions you have
at any time.
In appreciation for your time, partners will receive
compensation for attendance at meetings and
activities.
If you are interested in joining our team or would like more information:
Please contact Meredith Conboy, Research Assistant, The Ottawa Hospital Research Institute
Email:mconboy@ohri.ca